Skip to main content

Equibles does not estimate personal net worth.

Get an email with a short summary when Integra Lifesciences Holdings Corp publishes a filing, an earnings call transcript or a press release.

Get IART alerts

About Lea Knight

Lea Knight is recorded as CFO at Integra Lifesciences Holdings Corp (IART). The newest filing on record that lists Lea Knight as CFO at Integra Lifesciences Holdings Corp (IART) is dated April 6, 2026. The proxy statement of Integra Lifesciences Holdings Corp reports total compensation of $2,882,994 for Lea Knight in fiscal 2025, including a base salary of $638,646. Disclosed compensation is on record for 3 fiscal years. Lea Knight has spoken on 12 earnings calls and 3 other investor events across 1 company, most recently for Integra Lifesciences Holdings Corp on September 9, 2026. Integra Lifesciences Holdings Corp is classified in the Medical Devices industry within the Healthcare sector. Other leadership on record at Integra Lifesciences Holdings Corp includes Dr. Stuart M. Essig (CEO), Mojdeh Poul (CEO and Board Member), Stuart M. Essig (CEO and Chairman) and 7 others.

Lea Knight on recent calls

“Let me take that, and I'll start with, first, I'll point to our performance in the first two quarters of this year.”
CFO, Wells Fargo 21st Annual Healthcare Conference ·
“I want to begin by thanking our team for their continued strong execution in the second quarter. Turning to slide five, I will cover our second quarter financial results.”
CFO, Integra LifeSciences Q2’2026 Earnings Call ·
“And Matt, thank you for the opportunity to be here. We appreciate it. So certainly, Integra Life Sciences is a global medical technology company with leadership in both neurosurgery and regenerative medicine.”
CFO, Jefferies Global Healthcare Conference ·
“So as you mentioned last week, as part of our earnings, we announced the fact that Moshe Pohl and the board came to a mutual decision for her to step down as CEO, and now Seward occupies the position of both chairman and CEO.”
CFO, BofA Securities 2026 Healthcare Conference ·
“I'd like to first thank our team for their contributions to our first quarter results. We delivered strong revenue and adjusted earnings per share in the quarter, reflecting solid product demand, improving supply execution and remediation, and the continued positive impact of our transformation.”
CFO, Integra Lifesciences Holdings Corp Q1 FY2026 Earnings Call ·

Affiliation history

Company network

Leadership on record at Integra Lifesciences Holdings Corp

Executive compensation

Compensation components disclosed in company proxy statements. Amounts are nominal USD; total is the company-reported figure.

Fiscal year Company Salary Total
2025 Integra Lifesciences Holdings Corp (IART) $638,646 $2,882,994
2024 Integra Lifesciences Holdings Corp (IART) $616,662 $3,145,466
2023 Integra Lifesciences Holdings Corp (IART) $295,385 $1,673,147

Recent activity

Show 3 earlier activities